Cornercap Investment Counsel Inc Pacira Bio Sciences, Inc. Transaction History

Cornercap Investment Counsel Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$25.5 - $31.51 $9,486 - $11,721	-372 Reduced 1.05%	35,003 $1 Million
Q4 2023 Jan 30, 2024	BUY	$26.32 - $34.31 $114,965 - $149,866	4,368 Added 14.09%	35,375 $1.19 Million
Q3 2023 Nov 13, 2023	BUY	$30.68 - $40.09 $951,294 - $1.24 Million	31,007 New	31,007 $951,000
Q2 2019 Aug 14, 2019	SELL	$36.57 - $47.97 $482,541 - $632,964	-13,195 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$36.47 - $42.17 $481,221 - $556,433	13,195 New	13,195 $502,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Cornercap Investment Counsel Inc with notifications on news.